Pharmaceutical packaging is undergoing profound change in 2026. European serialisation requirements, the growth of smart packaging and increasing attention to sustainability are reshaping priorities for businesses and design studios.
1. Smart packaging and traceability
The EU Falsified Medicines Directive (Directive 2011/62/EU), together with Commission Delegated Regulation (EU) 2016/161, introduced safety features including unique identifiers for most prescription medicines. In 2026, connected packaging goes further. Alongside Data Matrix codes used for verification, dynamic QR codes can connect patients to up-to-date package leaflets, medicine-use tutorials and supply-chain information. Packaging becomes a digital interface.
2. Sustainability and environmentally responsible materials
The EU Packaging and Packaging Waste Regulation (PPWR), Regulation (EU) 2025/40, sets ambitious packaging reduction and recyclability requirements, with phased deadlines and specific provisions for pharmaceutical packaging. This means reassessing materials, structures and processes: FSC-certified paperboard cartons, water-based inks and reduced material thickness without compromising product protection. A design studio must balance regulatory compliance, environmental sustainability and visual quality — a challenge that demands specialist knowledge and experience.
3. Accessibility and readability
Accessibility is an increasingly important priority in pharmaceutical packaging. European readability guidance addresses type size and colour contrast, while EU medicines legislation requires Braille on relevant packs. Typography is therefore a safety-critical discipline: every choice of typeface, size, leading and spacing affects how easily patients can read essential information. A studio with decades of sector experience understands these constraints and turns them into design opportunities.
4. AI and automation in artwork production
Artificial intelligence is transforming pharmaceutical packaging artwork production. Automated adaptation of multilingual layouts, assisted regulatory checks and photorealistic mockups for internal approval can significantly reduce time and cost. But AI is a tool, not a replacement: experienced designers must direct it, correct it and validate its output. Studio Tamoni has integrated AI into its workflow for over a year, with tangible, measurable results.
Want to understand what these trends mean for your pharmaceutical packaging?